• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Device Problem Break (1069)
Patient Problems Ischemia (1942); Pain (1994); Stenosis (2263)
Event Date 11/03/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Udi#: in the absence of a reported part number, the udi cannot be calculated.The device was not returned for analysis.The lot history record for this product could not be reviewed and a similar incident query could not be performed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effects of ischemia, pain, and restenosis are listed as potential patient effects associated with the use of the device and are listed in the supera instruction for use.The investigation was unable to determine cause for the reported stent fracture and subsequent patient effects.It may be possible that the supera stent was subjected to stress, fatigue or repetitive movement due to anatomical conditions or location of the stent; however, this could not be confirmed.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported that the procedure was performed on (b)(6) 2018 to treat chronic totally occluded lesion in the distal superficial femoral artery (sfa) and popliteal.The patient was symptomatic approximately four weeks prior to the procedure, and had presented with critical ischemia / peripheral arterial disease stage 3 with pain at rest.During the procedure, it was discovered that a supera stent had already been implanted in the patient in approximately 2015.The stent was located partially in the popliteal and partially in the distal sfa, and was occluded due to restenosis and broken in the p-1 segment.A non-abbott self-expanding stent graft was used to treat the restenosis and broken portion of the supera stent.There was no adverse patient sequela and no reported clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Hospitalization added to outcomes attributed to adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8166351
MDR Text Key130458564
Report Number2024168-2018-09723
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/14/2018
Initial Date FDA Received12/14/2018
Supplement Dates Manufacturer Received12/14/2018
Supplement Dates FDA Received12/14/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-